2 unknown, 1 active not recruiting. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Unknown 2, Active not recruiting 1 |
Follow folfirinox: new trials by email Literature Review of folfirinox trials Research Report on folfirinox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma Modified Folforinox (mFFX) - Resectable Pancreatic Cancer | Not applicable | Active not recruiting | University Health Network, Toronto | 84 | 2020-08-21 | 2026-03-12 |
| Pancreatic Locally Advanced Irresectable Cancer Ablation Radiofrequency ablation (RFA), FOLFIRINOX, Nab-paclitaxel plus Gemcitabine - Locally Advanced Pancreatic Cancer | Not applicable | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 228 | 2015-04-07 | 2018-10-01 |
| Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer FOLFIRINOX Regimen - Pancreas Cancer, Localized Pancreas Cancer | Not applicable | Unknown | Baylor Research Institute | 30 | 2012-10-01 | 2017-01-31 |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Baylor Research Institute (1) · University Health Network, Toronto (1)
Canada (1) · Netherlands (1) · United States (1)
Jennifer Knox, MD (1) · Scott Celinski, MD (1)